Cytokinetics Inc To Discuss COURAGE-ALS Update Call Transcript
Good morning, and welcome, ladies and gentlemen, to Cytokinetics Courage-ALS update call. At this time, I would like to inform you that this call is being recorded. (Operator Instructions) I will now turn the call over to Diane Weiser, Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Good morning, Wangen and thanks for joining us on the call today to discuss results of the second interim analysis of Courage-ALS. On the call with me today are Robert Blum, President and Chief Executive Officer; and Fady Malik, EVP of Research and Development. Please note that portions of the following discussion, including our responses to questions contain statements that relate to future events and performance rather than historical facts and constitute forward-looking statements. Our actual results may differ materially from those projected in these forward-looking statements.
Additional information concerning factors that could cause our actual results to differ materially from
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |